Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Accumulated Expenses: 2011-2024

Historic Accumulated Expenses for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $23.7 million.

  • Mimedx Group's Accumulated Expenses rose 37.08% to $27.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.6 million, marking a year-over-year increase of 37.08%. This contributed to the annual value of $23.7 million for FY2024, which is 5.88% up from last year.
  • As of FY2024, Mimedx Group's Accumulated Expenses stood at $23.7 million, which was up 5.88% from $22.4 million recorded in FY2023.
  • Mimedx Group's Accumulated Expenses' 5-year high stood at $30.5 million during FY2020, with a 5-year trough of $20.9 million in FY2022.
  • For the 3-year period, Mimedx Group's Accumulated Expenses averaged around $22.3 million, with its median value being $22.4 million (2023).
  • As far as peak fluctuations go, Mimedx Group's Accumulated Expenses declined by 22.54% in 2021, and later grew by 7.18% in 2023.
  • Yearly analysis of 5 years shows Mimedx Group's Accumulated Expenses stood at $30.5 million in 2020, then dropped by 22.54% to $23.6 million in 2021, then dropped by 11.61% to $20.9 million in 2022, then climbed by 7.18% to $22.4 million in 2023, then climbed by 5.88% to $23.7 million in 2024.